Abstract:Objective: The aim of this study is to investigate the value of modified parameters derived from dual-phase contrast-enhanced computed tomography (CT) in predicting angiogenesis within pheochromocytoma. Method: A total of 31 patients with pathologically confirmed pheochromocytoma underwent preoperative dual-phase contrast-enhanced CT scanning, wherein modified CT enhancement parameters, namely maximum enhancement difference (∆H) and maximum enhancement velocity (V), were quantified. Subsequently, postoperative specimens were evaluated by pathological section, while microvessel density (MVD) and vascular endothelial growth factor (VEGF) levels were counted. We conducted comparative analyses to assess disparities in maximum enhancement difference and enhancement velocity between groups characterized by high and low VEGF expression. Furthermore, correlations between maximum enhancement difference, enhancement velocity, and MVD were examined, along with an assessment of the association between maximum enhancement difference, VEGF expression, and MVD at the point of maximal enhancement difference occurrence. Results: In the study group, unilateral pheochromocytoma was observed in 31 cases, with 19 cases of arterial phase enhancement and 12 cases displaying venous phase enhancement. The range of maximum enhancement difference (ΔH) spanned from 24 to 102 HU, while the range of maximum enhancement velocity (V) extended from 0.40 HU/s to 4.08 HU/s. Analysis revealed a significant elevation in MVD value within the arterial phase enhancement group compared to the venous phase enhancement group. Additionally, a positive correlation was discerned between the maximum enhancement difference, V, and MVD. Notably, both ∆H and V exhibited statistically significant elevations in the high VEGF expression group relative to the low VEGF expression group. Furthermore, a positive correlation was observed between both ΔH and V and VEGF expression levels. Conclusion: Increased values of ∆H and V are indicative of heightened MVD and VEGF expression. Consequently, the modified parameters derived from dual-phase contrast-enhanced CT scanning serve as predictive markers for angiogenesis in adrenal pheochromocytoma.

Correlation of Hypoxia Inducible Factors, Vascular Endothelial Growth Factor Receptor 2, and Microvessel Density Expressions with Angiogenesis in Adrenocortical Tumours

HPA-1 and VEGF Expression and Microvessel Density in Adrenocorticai Carcinoma

Relationship of VEGF, VEGFR-2 and MVD Expressions in Adrenal Cortical Carcinoma

Expressions of STAT 3,VEGF and MVD and the significance in adrenal cortical carcinoma

Significance of Heparanase-1 and Vascular Endothelial Growth Factor in Adrenocortical Carcinoma Angiogenesis: Potential for Therapy

Relationship of IGF-2,VEGFR-2,PDGFR and HPA expressions in adrenal cortical carcinoma

Expression of STAT3 and IGF2 in Adrenocortical Carcinoma and Its Relationship with Angiogenesis.

Expression and Correlative Investigation of Hypoxia Inducible Fector-1Α and Vasculare Endothelial Growth Factor in Salivary Adenoid Cystic Carcinoma

Molecular Cluster Mining of Adrenocortical Carcinoma Via Multi-Omics Data Analysis Aids Precise Clinical Therapy.

Tumoral Angiogenesis in Both Adrenal Adenomas and Nonadenomas: a Promising Computed Tomography Biomarker for Diagnosis

[Expression of Hypoxia-Inducible Factor-1-alpha, Hypoxia-Inducible Factor-2Alpha and Vascular Endothelial Growth Factor in Sporadic Clear Cell Renal Cell Renal Cell Carcinoma and Their Significance in the Pathogenesis Thereof].

Expression of the SF-1 in adrenal cortical neoplasm : Correlation with clinical significance

Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor and their relationship to associated with clinicopathologic parameters in salivary adenoid cystic carcinoma

Correlation between expression of hypoxia-factor-1αmRNA and angiogenesis in gastric adenocarcinoma

Expression and Invasion Associativity Investigation of Hypoxia Inducible

Expression of FSCN1 and FOXM1 Are Associated with Poor Prognosis of Adrenocortical Carcinoma Patients

The Increased TLR4 and EGFL 7 Expressions in Adrenal Cortical Carcinoma

Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma.

Predicting angiogenesis in adrenal pheochromocytoma: the role of modified parameters from contrast-enhanced CT

[Relationship of Hypoxia-Inducible Factor 1 Alpha (Hif-1Alpha) Gene Expression with Vascular Endothelial Growth Factor (VEGF) and Microvessel Density (MVD) in Human Colorectal Adenoma and Adenocarcinoma].

The diagnosis and treatment of adrenocortical carcinoma:report of 39 cases